GUJCET 2026 application deadline extended to January 16
GSHSEB extends GUJCET 2026 application deadline to Jan 16 with a Rs 1,000 late fee. Exam scheduled for March 29 for engineering and pharmacy admissions. Apply now at gujcet.gseb.org.
Category : Search result: generic pharmacy India
Natco Pharma Sues to Revoke Novo Nordisk's Semaglutide Patent
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Japanese firms expand India tech centres to tap talent
Japanese giants like MUFG, Nidec, and Polyplastics are setting up tech centres in India. Driven by an ageing population and China risk, they aim to tap India's deep talent pool for AI, cybersecurity, and engineering. Read more.
NZ PM Calls India FTA a Landmark Deal for Jobs & Growth
New Zealand PM Christopher Luxon hails the historic Free Trade Agreement with India as a major boost for jobs, exports, and economic growth. Key details inside.
GUJCET 2026 Registration Deadline is January 6
The GSEB closes GUJCET 2026 registration today, Jan 6, 2026. Apply now for engineering, diploma & pharmacy courses in Gujarat. Exam on March 29.
India's New Pharma Licence Regime to Fix Accountability
India plans a new wholesale licensing system for bulk drugs and a supplier database to enhance traceability and accountability in its $50-billion pharmaceutical market, following global safety concerns.
Atul Vivek Named CEO of Nxtcell India, Alcatel Brand
Nxtcell India appoints Atul Vivek as CEO effective Jan 1, 2026. With 20 years of leadership experience from Realme, Samsung, and others, he will drive Alcatel's smartphone and AIoT expansion. Read more.
Shark Tank India Season 5: New Sharks, Release Time
Shark Tank India Season 5 premieres Jan 5, 2026, with new sharks joining the panel. Get all details on judges, timing, and where to watch the business reality show.
Generic Drugs as Good as Brands, Cost Far Less: Study
A citizen-funded study finds generic medicines, including Jan Aushadhi, match quality of expensive brands. Experts urge trust in affordable options for better treatment adherence. #Healthcare #India
Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
3 Held in Bangladesh for Brutal Murder of Pharmacy Owner
Bangladesh's Rapid Action Battalion arrests three key suspects in the brutal murder of pharmacy owner Khokon Chandra Das. Details on the investigation and the shocking attack.
Generic Semaglutide to Create Rs 50,000 Cr Market
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Generic Semaglutide to Create Rs 50bn+ Revenue Opportunity
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
Semaglutide Patent Expiry Creates Rs 50,000 Cr Opportunity
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Weight-loss drugs poised for takeoff, cancer care expands in 2026
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
India's 2026 Hiring Boom: 12 Million Jobs Expected
Indian companies plan a major hiring surge in 2026, creating 10-12 million jobs. Driven by tech and diversity goals, firms like EY, Tata Motors, and Diageo are expanding teams. Read the full outlook.
India's 2025 Auto Boom: JSW MG, M&M, Kia, Skoda Lead Growth
India's auto sector ended 2025 with robust growth. JSW MG, Mahindra, Kia & Skoda reported record sales, driven by EVs and strong demand. Get all the key figures and insights here.
India's 2025 Health Shift: Prevention, Generics & Digital Tools
From preventive screenings to affordable generics, 2025 reshaped India's health priorities. Discover the key trends that made wellness a daily habit and what it means for 2026.
Vadodara student wins Schott Fiolax Scholarship 2025
Priya S K Sharma, an M.Pharm student at MSU Vadodara, secures the Schott Fiolax Scholarship 2025 for academic excellence in pharmaceutical chemistry. Read her inspiring story.
UHSR Rohtak Declares 2025 Exam Results: Download PDFs
Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak has published results for B.Pharmacy, GNM, and M.Pharma exams. Download official gazettes from uhsr.ac.in.
GUJCET 2026 Application Deadline Extended to Jan 6
GSHSEB extends GUJCET 2026 online application deadline to January 6, 2026. Get details on exam dates, fees, and how to apply for engineering and pharmacy courses.
AP SBTET March-April 2025 Results Released
AP SBTET has announced the March-April 2025 exam results for Diploma and Pharmacy courses. Download your scorecard now from sbtet.ap.gov.in and plan your next steps.
AP SBTET 2025 Results Out for Diploma, Pharmacy Courses
AP SBTET has announced the March-April 2025 exam results for Diploma & Pharmacy courses. Download your marksheet from sbtet.ap.gov.in now. Verify details like grades and qualifying status.
US Vlogger's Emotional Farewell to India Goes Viral
A US-based vlogger's heartfelt goodbye video from India, filmed on a two-wheeler, goes viral. He shares how the country's warmth and daily life changed his perspective. Read his emotional journey.
NBEMS 2026 Tentative Exam Schedule Released
NBEMS has announced the provisional schedule for major medical exams from Jan to June 2026. Check all dates for FMGE, DNB, GPAT, and more. Final dates subject to change.
India's 2026 Foreign Policy: Key Challenges & Opportunities
As India enters 2026, it faces critical tests in trade talks with the US, volatile neighbours, and balancing great-power ties. This analysis explores Delhi's strategic choices in a fractured world.
India's 2026 Diplomacy: Balancing Autonomy & Ambition
After a turbulent 2025 marked by conflict and trade wars, India enters 2026 with crucial choices on Pakistan, US ties under Trump, and key summits. Explore the high-stakes diplomatic roadmap ahead.
2025's Top Smartphone Launches in India: Full List
A comprehensive look at the biggest smartphone launches in India for 2025, featuring Samsung, Apple, Google, OnePlus, Xiaomi, and more. Discover the flagships and budget kings that defined the year.
Govt Mulls 1-Year Extension for Pharma GMP Norms
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
Page 1 of 4